MHJ HY24: PBT fell 59.7% on a flat revenue line with dividend suspended

EBITDA dropped 30.3% to NZ$60.8m, operating profit halved (-51.0%) to NZ$28.8m, PBT fell 59.7% to NZ$21.9m and NPAT fell 59.0% to NZ$15.4m. Annolyse's historical baseline puts PBT growth in a 4.3%–30.3% range with a 14.4% mean, so this print sits well below normal.

The cash and balance-sheet picture moved with the P&L. Operating cash flow fell 53.7% to NZ$22.0m and pre-lease free cash flow collapsed to NZ$9.1m versus the historical NZ$57.3m mean. Cash on hand fell from NZ$78.7m to NZ$22.8m, gross borrowings rose to NZ$34.4m, and net position swung from NZ$66.2m net cash to NZ$11.6m net debt. No interim dividend was declared, against 4.0cps in the prior comparable.

With sales flat, EBITDA down 30.3% and operating profit down 51.0% imply a step-down in unit economics rather than volume deleverage. Australia, the dominant segment at 55.8% of revenue, grew sales NZ$11.7m but its segment result fell from NZ$38.4m to NZ$25.2m. This matters because the read on the business shifts from a cyclical sales softness story to a margin-structure problem.

Inventory built above the historical range. Inventory days reached 110.4, above the historical 99.1–107.7 band, with stock up NZ$21.6m year-on-year to NZ$219.8m. That working-capital absorption is the proximate driver of the OCF drop and explains why cash conversion (OCF/EBITDA) fell from 54.5% to 36.2%. If the build is deliberate (range or store-rollout stocking) it is timing; if it is unsold seasonal stock, gross-margin risk lies ahead.

Capital position weakened and the dividend was withheld. ROE fell from 19.4% to 7.9%, the group moved from net cash to net debt, and no interim dividend was declared. Pre-lease FCF would not have covered the prior 4.0cps payout under the prior 46.4% pre-lease FCF payout ratio at this earnings level, so the dividend pause is consistent with the cash math but signals reduced board confidence in the second-half cash trajectory.

The supplied second-half shape is informative on its own terms: HY23 was 57.7% of FY23 revenue, 74.9% of FY23 EBITDA and 106.8% of FY23 NPAT, implying FY23 H2 NPAT was already negative at -NZ$2.4m. HY24 has now rebased the first half lower, so absent a sharp margin recovery the FY24 NPAT outcome looks materially below FY23 on the supplied seasonality.

The release does not support a view on whether HY24 weakness reflects a discrete promotional or inventory-clearing period or a more durable margin reset. That uncertainty is the central read-through for the second half.

Effective tax rate of 29.6% sits within the historical 28.1%–30.8% band, so the NPAT print is not tax-distorted; the -0.7 percentage-point gap between PBT growth (-59.7%) and NPAT growth (-59.0%) is incidental. That means PBT carries the same operating signal as NPAT, and both are below the historical range. There is no disclosed one-off, restructuring item or discontinued operation in the supplied data to set aside.

Cash conversion deterioration is partly working-capital-driven (inventory +NZ$21.6m) and could reverse if stock sells through, but the margin compression behind the EBITDA fall is not balance-sheet flattering; it is the durable component. Capex was 3.6% of revenue (down from 4.0%), so the cash drop is not investment-led.

• Pre-lease FCF: NZ$9.1m vs NZ$33.2m prior; FCF/NPAT 59.1% vs 88.2%.
• Working capital absorption is the swing factor, but margin is the structural issue.

This briefing cannot assess like-for-like store sales, FX translation effects, or management's qualitative explanation of the margin step-down because that commentary is not present in the supplied excerpts.